By Zach Hales, Associate Director, Product Management
The adoption of technology in clinical research is a traditionally slow endeavor. However, in 2020, a year riddled with unparalleled challenges, the industry adapted and responded in rapid fashion. Measures were taken to allow for continuity of studies, all while shortening timelines and ensuring safety and flexibility of care. This flexibility can be seen through trial decentralization – enabling care to be continued through varying methods, whether bringing care to the patient’s home, allowing patients to benefit from local labs or utilizing technology to complete trial requirements.
This response by the industry was impressive and perhaps provides a glimpse into the future of clinical research. But what does the future look like? While we cannot be certain, I will leave you with some of my thoughts.